Back to BlackRock, Inc. BlackRock, Inc.

MREOMREO
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in MEREO BIOPHARMA GROUP PLC

BlackRock, Inc. holds 69,678 shares of MREO (MEREO BIOPHARMA GROUP PLC), worth $22,137 as of 2026-Q2. The position was decreased (-77.0% shares).

Current Value

$22,137

Current Shares

69,678

Total Value Change

-$933,430

Total Shares Change

-203,341

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
69,678
-77.0%
$22,1370.0%$0.32
0
2026-Q1
Decreased
302,991
-3.1%
$99,9860.0%$0.41
0
2025-Q4
Decreased
312,613
-29.6%
$130,2650.0%$0.37
0
2025-Q3
Decreased
444,004
-2.5%
$914,6480.0%$1.96
0
2025-Q2
Increased
455,365
+66.0%
$1.2M0.0%$2.66
25
2025-Q1
Increased
274,361
+0.5%
$617,3130.0%$2.30
17
2024-Q4
New
273,019
-
$955,5670.0%$3.52
38

Other major holders of MREO: Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used